EHRA Premium Access

Clinical characteristics predisposing to appropiate ventricular therapy in patients with implanted cardioverter-defibrilator for primary prevention of sudden cardiac death.

Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)

Congress Presentation

About the speaker

Doctor Francisco Mendez Zurita

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)
0 follower

20 more presentations in this session

Prospective study of implantable cardioverter-defibrillator activation in hypertrophic cardiomyopathy patients in greece

Speaker: Doctor P. Dilaveris (Athens, GR)

Thumbnail

Total cosine R-to-T for predicting ventricular arrhythmic and mortality outcomes: a systematic review and meta-analysis

Speaker: Professor G. Tse (Hong Kong, CN)

Thumbnail

Proposed risk factors of sudden cardiac death in hypertrophic cardiomyopathy patients

Speaker: Doctor V. Kaplunova (Moscow, RU)

Thumbnail

Discrepancy in ejection fractions measured by echocardiography and magnetic resonance imaging in heart failure patients with severe left ventricular dysfunction

Speaker: Doctor J. Park (Busan, KR)

Thumbnail

Mid-term mortality after implantable cardioverter-defibrillator:causes and predictors

Speaker: Doctor J. Acosta Martinez (Seville, ES)

Thumbnail

Access the full session

Poster session 2 - Sudden cardiac death and implantable defibrillators

Speakers: Doctor F. Mendez Zurita, Doctor P. Dilaveris, Professor G. Tse, Doctor V. Kaplunova, Doctor J. Park...
Thumbnail

About the event

Image

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations